Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
3.410
+0.070 (2.10%)
At close: May 30, 2025, 4:00 PM
3.450
+0.040 (1.17%)
After-hours: May 30, 2025, 7:58 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Novel Therapies for Cancers
683.00K
Log In
Log In
Log In
Log In
Upgrade
Novel Therapies for Cancers Growth
39.96%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
683.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
39.96%
Log In
Log In
Log In
Log In
Upgrade